Literature DB >> 21373798

Efficacy of total joint arthroplasty in patients with established rheumatoid arthritis: improved longitudinal effects on disease activity but not on health-related quality of life.

Shigeki Momohara1, Eisuke Inoue, Katsunori Ikari, Koichiro Yano, Asami Tokita, Taku Suzuki, Yu Sakuma, Ryo Hiroshima, Kosei Kawakami, Ikuko Masuda, Takuji Iwamoto, Atsuo Taniguchi, Hisashi Yamanaka.   

Abstract

Though excellent clinical results have been reported for total joint arthroplasty (TJA) in rheumatoid arthritis (RA) patients, the longitudinal effects of TJA on pain, physical function, and health-related quality of life in RA patients remain unknown. This study aimed to assess changes in disease activity and health-related quality of life after TJA in patients with established RA. We analyzed the effect of total knee arthroplasty (TKA) and total hip arthroplasty (THA) on RA disease activity in an observational cohort of RA patients. Of the registered RA patients, 333 TKA and 77 THA patients were followed for 5 years after surgery. RA disease activity and health-related quality of life were measured using the Disease Activity Score 28 (DAS28) and a Japanese version of the Stanford health assessment questionnaire (J-HAQ). The mean DAS28 in TKA patients decreased from 4.66 (preoperatively) to 4.02 (3 years postoperatively) and to 3.94 (5 years postoperatively); the mean DAS28 in THA patients decreased from 4.41 (preoperatively) to 3.99 (3 years postoperatively) and to 3.92 (5 years postoperatively). The mean J-HAQ for TKA remained essentially unchanged, ranging from 1.48 (preoperatively) to 1.45 (3 years postoperatively) and to 1.47 (5 years postoperatively); the mean J-HAQ for THA also remained unchanged, ranging from 1.74 (preoperatively) to 1.74 (3 years postoperatively) and to 1.73 (5 years postoperatively). Of the total J-HAQ score, the lower limb score improved while the upper limb score worsened. Although TKA and THA improve clinical outcomes in damaged knees and hips and have a positive secondary systemic effect on RA disease activity, they have not had a continuously good effect on the measures of health-related quality of life. We conclude that tight control of RA disease activity is indicated for those patients with TKA and/or THA.

Entities:  

Mesh:

Year:  2011        PMID: 21373798     DOI: 10.1007/s10165-011-0432-9

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  6 in total

1.  Rheumatoid Arthritis Flares After Total Hip and Total Knee Arthroplasty: Outcomes at One Year.

Authors:  Susan M Goodman; Serene Z Mirza; Edward F DiCarlo; Diyu Pearce-Fisher; Meng Zhang; Bella Mehta; Laura T Donlin; Vivian P Bykerk; Mark P Figgie; Dana E Orange
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-05-14       Impact factor: 4.794

2.  Cementless total knee arthroplasty in chronic inflammatory rheumatism.

Authors:  Jonathan Buchheit; Antoine Serre; Xavier Bouilloux; Marc Puyraveau; Laurent Jeunet; Patrick Garbuio
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-09-17

3.  [Which kind of structures and facilities are needed for the care of elderly patients with rheumatic diseases?].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2014-04       Impact factor: 1.372

4.  Hip score and disease activity correlation in patients with rheumatoid arthritis after total hip arthroplasty.

Authors:  Hiroki Wakabayashi; Masahiro Hasegawa; Kakunoshin Yoshida; Kusuki Nishioka; Akihiro Sudo
Journal:  Int Orthop       Date:  2013-05-03       Impact factor: 3.075

5.  Biologic-free remission by orthopaedic surgery in non-responder to infliximab for rheumatoid arthritis.

Authors:  Katsuaki Kanbe; Junji Chiba; Yasuo Inoue; Masashi Taguchi; Akiko Yabuki
Journal:  Springerplus       Date:  2015-10-13

6.  The effect of rheumatoid arthritis on patient-reported outcomes following knee and hip replacement: evidence from routinely collected data.

Authors:  Edward Burn; Christopher J Edwards; David W Murray; Alan Silman; Cyrus Cooper; Nigel K Arden; Rafael Pinedo-Villanueva; Daniel Prieto-Alhambra
Journal:  Rheumatology (Oxford)       Date:  2019-06-01       Impact factor: 7.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.